LipoScience (LPDX) Q4 2012 Results March 27, 2013 4:30 PM ET
Executives
Bob Yedid - IR
Rick Brajer - President & CEO
Lucy Martindale - EVP & CFO
Tim Fisher - COO
Analysts
Bill Quirk - Piper Jaffray
Dan Arias - UBS
Matt Taylor - Barclays
Operator
Good day ladies and gentlemen and thank you for standing by and welcome to the LipoScience Fourth Quarter and Full Year 2012 Earnings Conference Call. (Operator Instructions). It's now my pleasure to turn the floor to Bob Yedid with ICR. Please go ahead.
Bob Yedid
Thank you Joey. Good afternoon everyone and welcome to LipoScience’s fourth quarter 2012 financial results conference call. Before we begin I will read the following Safe Harbor Statement. Statements or comments made on this conference call maybe forward-looking statements and may include but are not necessarily limited to financial projections or other statements regarding the company’s plans, objectives, expectations or intentions. These matters involve certain risk and uncertainties. The company’s actual results may differ materially from those projected or suggested at any forward-looking statements due to a variety of factors which are discussed in detail in the company’s filing with the Securities and Exchange Commission. Joining the call today are Rick Brajer, President and Chief Executive Officer and Lucy Martindale, Executive Vice President and Chief Financial Officer. After our prepared remarks we will turn the call back to the operator for your questions. It is now my pleasure to turn the call over to Rick. Rick?
Rick Brajer
Thank you Bob and good afternoon everyone. Thank you for joining the call. So this is our first call as a public company, I will describe both our strategy and our current priorities in detail. I’ll then turn it over to Lucy Martindale our CFO to review the fourth quarter and full
- Read more current LPDX analysis and news
- View all earnings call transcripts